Glaxo Smith Kline (BIOC)
Egyptian Exchange · Egypt · prices in EGP · close of 27 Oct 2026
Key indicators
| Last close | EGP 258.24 |
|---|---|
| 52-week range | 55.10 – 609.00 |
| Return, 1 month / 3 months | +8.3% / +80.8% |
| Return, 1 year / 3 years | +256.5% / +724.4% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 44 |
| Volatility (1 year) | 88.4% |
| Worst drawdown (1 year) | -60.3% |
| Average daily value traded | 143.73M EGP |
| Dividend yield | 0.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
Summary
Glaxo Smith Kline (BIOC) trades on the Egyptian Exchange in Egypt. It last closed at EGP 258.24 on 27 October 2026.
Its price-based Market X-Ray is 61 out of 100 (a fair price profile), ranking 77 of 276 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 256.5% and over the last three months it rose 80.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Egyptian Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 70 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 66.8% | ||
| From 52-week high | -53.0% | ||
| Momentum | 98 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 80.8% | ||
| 6-month return | 279.9% | ||
| 12-month return, skipping the last month | 229.1% | ||
| Stability (higher is calmer) | 11 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 88.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -60.3% | ||
| Liquidity | 95 · Strong | Trades actively. | |
| Average daily value traded | 143.73M EGP | ||
| Zero-volume days | 0.0% | ||
| Income | 20 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.4% | ||
| Years with dividends | 4 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −8.5% |
|---|---|
| 1 month | +8.3% |
| 3 months | +80.8% |
| 6 months | +279.9% |
| 1 year | +256.5% |
| 3 years | +724.4% |
| 5 years | +1,374.0% |
Signals
| 50-day / 200-day average | 322.30 / 154.84 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 30.91 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 12 Jan 2026 | EGP 1.0000 |
| 18 Jul 2024 | EGP 0.7500 |
| 4 Jul 2023 | EGP 0.7500 |
| 4 Jan 2023 | EGP 3.0000 |
| 20 Sep 2022 | EGP 0.7500 |
| 5 Jul 2021 | EGP 0.5000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Egyptian Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.